Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/196891
Kind Code:
A1
Abstract:
The present invention discloses a group of polycyclic carbamoylpyridone derivatives, pharmaceutical compositions, and a use thereof. The structure of the polycyclic carbamoylpyridone derivatives of the present invention is represented by formula (VII). The polycyclic carbamoylpyridone derivative of the present invention functions as an inhibitor of influenza 5' cap-like structure (CAP)-dependent endonuclease activity and can be used to treat a cold caused by the influenza virus. The present invention also discloses a pharmaceutical composition comprising the polycyclic carbamoylpyridone derivatives, a pharmaceutically acceptable carrier, and a method using the pharmaceutical composition to inhibit proliferation of the influenza virus.

Inventors:
ZHU XIAOYUN (CN)
JIANG WEIPING (CN)
Application Number:
PCT/CN2019/082195
Publication Date:
October 17, 2019
Filing Date:
April 11, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ANDIKANG WUXI BIOLOGICAL TECH CO LTD (CN)
International Classes:
A61K31/53; C07D498/14; C07D471/14
Domestic Patent References:
WO2018030463A12018-02-15
Foreign References:
CN108440564A2018-08-24
CN109503625A2019-03-22
CN107709321A2018-02-16
CN201810323355A2018-04-11
Other References:
WANG, SHIZHEN: "Part VI Research of Nuclear Medicine", MOLECULAR NUCLEAR MEDICINE (2ND EDITION, 30 April 2004 (2004-04-30), pages 417 - 418, XP009524204
RAJ SNER ET AL., COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, vol. 47, no. 1, 1987, pages 65 - 71
LGA M.ROCHOVANSKY, VIROLOGY, vol. 73, 1976, pages 327 - 338
See also references of EP 3778608A4
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: